About Synapticure
Synapticure launched in 2022 to serve individuals living with ALS, and we continue to expand our care for additional neurodegenerative diseases including Parkinson’s Disease, Huntington’s Disease, Alzheimer’s Disease and other Dementias. Remote by design, we are backed by Google Ventures, Optum Ventures and other leading healthcare investors.
Synapticure aims to provide individuals living with neurodegenerative disease and their families access to the best care, while fueling the advancement of personalized treatments. Our care teams create a guided journey for each patient that educates and empowers, while relentlessly working to obtain access to critical tests, clinical trials, and expert providers. Synapticure’s team of neurologists, behavioral health providers, and care coordinators serve patients in all 50 states and DC.
Over the next year we’ll be growing quickly to serve thousands of individuals and their families; to achieve this, we require optimistic, knowledgeable, and compassionate team members who are eager to build a new standard of care for ...